These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19765212)

  • 1. Multi-step binding of ADAMTS-13 to von Willebrand factor.
    Feys HB; Anderson PJ; Vanhoorelbeke K; Majerus EM; Sadler JE
    J Thromb Haemost; 2009 Dec; 7(12):2088-95. PubMed ID: 19765212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.
    Nowak AA; McKinnon TA; Hughes JM; Chion AC; Laffan MA
    J Thromb Haemost; 2014 Jan; 12(1):54-61. PubMed ID: 24406064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational stability and domain unfolding of the Von Willebrand factor A domains.
    Auton M; Cruz MA; Moake J
    J Mol Biol; 2007 Feb; 366(3):986-1000. PubMed ID: 17187823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide bond reduction of von Willebrand factor by ADAMTS-13.
    Yeh HC; Zhou Z; Choi H; Tekeoglu S; May W; Wang C; Turner N; Scheiflinger F; Moake JL; Dong JF
    J Thromb Haemost; 2010 Dec; 8(12):2778-88. PubMed ID: 20946172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
    Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
    J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.
    De Cristofaro R; Peyvandi F; Baronciani L; Palla R; Lavoretano S; Lombardi R; Di Stasio E; Federici AB; Mannucci PM
    J Biol Chem; 2006 Oct; 281(41):30400-11. PubMed ID: 16899464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.
    Gao W; Zhu J; Westfield LA; Tuley EA; Anderson PJ; Sadler JE
    J Biol Chem; 2012 Aug; 287(32):26944-52. PubMed ID: 22707719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.
    Jin SY; Skipwith CG; Zheng XL
    Blood; 2010 Mar; 115(11):2300-10. PubMed ID: 20075158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
    Perutelli P; Molinari AC
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
    Xiang Y; de Groot R; Crawley JT; Lane DA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
    Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
    Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.
    Wu JJ; Fujikawa K; McMullen BA; Chung DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18470-4. PubMed ID: 17121983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS-13.
    Lancellotti S; De Filippis V; Pozzi N; Oggianu L; Rutella S; Scaglione GL; Maset F; Peyvandi F; Mannucci PM; De Cristofaro R
    J Thromb Haemost; 2011 Aug; 9(8):1620-7. PubMed ID: 21605335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric activation of ADAMTS13 by von Willebrand factor.
    Muia J; Zhu J; Gupta G; Haberichter SL; Friedman KD; Feys HB; Deforche L; Vanhoorelbeke K; Westfield LA; Roth R; Tolia NH; Heuser JE; Sadler JE
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18584-9. PubMed ID: 25512528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.
    Deforche L; Roose E; Vandenbulcke A; Vandeputte N; Feys HB; Springer TA; Mi LZ; Muia J; Sadler JE; Soejima K; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2015 Nov; 13(11):2063-75. PubMed ID: 26391536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions.
    Dong JF
    J Thromb Haemost; 2005 Aug; 3(8):1710-6. PubMed ID: 16102037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
    Chen J; Ling M; Fu X; López JA; Chung DW
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis.
    Baldauf C; Schneppenheim R; Stacklies W; Obser T; Pieconka A; Schneppenheim S; Budde U; Zhou J; Gräter F
    J Thromb Haemost; 2009 Dec; 7(12):2096-105. PubMed ID: 19817991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.
    Rayes J; Hommais A; Legendre P; Tout H; Veyradier A; Obert B; Ribba AS; Girma JP
    J Thromb Haemost; 2007 Feb; 5(2):321-8. PubMed ID: 17087728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.